1. Home
  2. /
  3. Investments
  4. /
  5. SERB Pharmaceuticals

SERB Pharmaceuticals

SERB Specialty Pharmaceuticals is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases. Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs.

SERB is a global pharmaceutical group with a direct presence in Europe, in the Middle East and Australia, and over 80 countries including the US and Japan through a broad network of experienced distributors.

SERB-vectoriel
Team

Buyout

Status

Current

Geography

Europe

Ownership

Co-investment

Segment

Therapeutic Intervention

Entry Date

2021

Key Figures

Current

Status

1951

Creation Date

390

Number of Employees

2021

Investment Date

Mérieux Participations 3

Fund Name

Key Contacts

Related companies